International Oncology Program
Saint Petersburg, Russia
2-5 July, 2025
2-5 July, 2025
Discover breakthrough products, global biotech solutions, and the people behind the innovation.
Welcome to Saint Petersburg
We are delighted to welcome you to Saint Petersburg for a unique international oncology program.
This event fosters knowledge exchange, strengthens professional connections, and opens BIOCAD’s innovation ecosystem to international experts.
Beyond scientific exchange, explore the rich cultural heritage of Saint Petersburg — a city of art, music, and majestic architecture.
Venue of events
Dialogue for the Future: Shaping Tomorrow’s Care in Oncology
On July 2, we invite you to attend the special event “Dialogue for the Future: Shaping Tomorrow’s Care in Oncology”, a day of expert presentations and open discussion on emerging approaches in cancer care.
COSMOS SAINT-PETERSBURG
PRIBALTIYSKAYA HOTEL
PRIBALTIYSKAYA HOTEL
Venue of event
Dates: 3–5 July, 2025
Address: Korablestroiteley Str., 14, St. Petersburg, Russia
Web: https://pribaltiyskaya.cosmosgroup.ru/en
HOTEL ASTORIA
SAINT PETERSBURG
SAINT PETERSBURG
Venue of event
The Angleterre and Astoria hotels are part of a single hotel complex located in one building
Dates: 2 July, 2025
Address: Bol’shaya Morskaya Str., 39, St. Petersburg, Russia
Web: https://www.roccofortehotels.com/hotels-and-resorts/hotel-astoria
Congress details
On July 3, we are pleased to invite you to a satellite symposium and plenary reports as part of the XIth St. Petersburg International Oncology Forum «WHITE NIGHTS 2025».
International Oncology Forum «White Nights» is one of the largest events in cancer care, bringing together a wide range of specialists from Russia, neighboringcountries and beyond.
International Oncology Forum «White Nights» is one of the largest events in cancer care, bringing together a wide range of specialists from Russia, neighboringcountries and beyond.
Web: https://www.roccofortehotels.com/hotels-and-resorts/hotel-astoria
Address: Bol’shaya Morskaya Str., 39, St. Petersburg, Russia
Dates: 2 July, 2025
Venue of event
HOTEL ASTORIA
SAINT PETERSBURG
SAINT PETERSBURG
Web: https://pribaltiyskaya.cosmosgroup.ru/en
Address: Korablestroiteley Str., 14, St. Petersburg, Russia
Dates: 3 July, 2025
Venue of event
COSMOS SAINT-PETERSBURG
PRIBALTIYSKAYA HOTEL
PRIBALTIYSKAYA HOTEL
Web:
https://forum-onco.ru/en/
https://forum-onco.ru/en/
Travel & Practical Information
Russian Customs Rules for Travelers
It’s allowed to bring into Russia:
- 10.000 USD (and equivalent)
- 3 liters of alcohol
- 250 g of tobacco
- 5 kg of plant products
It’s allowed to take out of Russia:
- 10.000 USD
- (or equivalent in any currency)
- 5 kg of fish and seafood
- 250 g of caviar
Special permission should be issued for:
- Guns
- Strong medicines
- Precious metals and stones
- Items of cultural value
Exchange rates & Payments
- Ruble is the currency of the Russian Federation
- Bring cash (USD or EUR) to exchange
- Foreign bank cards don’t work!
- 1 USD ≈ RUR 79,60
1 EUR ≈ RUR 90,34as of June 25, 2025
Weather & Clothing Recommendations
In early July, the average temperature in St. Petersburg is around +21°C.
Evenings may be windy and cool.
We suggest bringing a light jacket or windbreaker, a hat, and an umbrella.
Accommodation Details
ANGLETERRE Hotel St. Petersbug
Dates: 1-6 July, 2025
Address: Malaya Morskaya Str., 24 , St. Petersburg, Russia
Hotel accomodation
Web:
https://www.angleterrehotel.com
https://www.angleterrehotel.com
The Angleterre and Astoria hotels are part of a single hotel complex located in one building
Agenda
- Arrival to St. Petersburg
- Transfer to the hotel
- Check-in at Angleterre Hotel St. Petersburg
- Lunch (Astoria Hotel)
- Dinner (Astoria Hotel)
7:00-9:00 | Breakfast (Angleterre Hotel, Michele restaurant) |
9:00-10:00 | Free time |
10:00-12:00 | Excursion to St. Isaac’s Cathedral |
12:00-13:00 | Lunch |
13:00-17:00 | BIOCAD Day: Dialogue for the Future: Shaping Tomorrow’s Care in Oncology |
17:00-18:00 | Free Time |
18:00-21:00 | Welcome Dinner (Astoria Hotel) |
7:00-9:00 | Breakfast (Angleterre Hotel, Michele restaurant) |
9:00-12:00 | Free time |
12:00-13:00 | Transfer to Congress Hall (Gathering of guests in the hotel lobby at 12:00) |
13:15-14:15 | Satellite symposium as part of the International Oncology Forum "White Nights 2025" |
14:15-15:50 | Lunch at “Maimun” reastaurant (Cosmos Pribaltiyskaya hotel) |
15:50-16:25 | Plenary reports as part of congress’s scientific program |
17:00-18:00 | Bus Tour |
18:30-21:00 | Dinner at “Magadan” restaurant |
21:00-22:00 | Transfer to the hotel |
6:00-9:00 | Breakfast at Michele restaurant, Angleterre Hotel |
8:45-10:00 | Transfer to manufacturing facility (Gathering of guests in the hotel lobby at 8:45) |
10:00-11:00 | Excursion to manufacturing facility / Lecture at the Lecture Hall |
11:00-12:00 | Lecture at the Lecture Hall / Excursion to manufacturing facility |
12:30-13:00 | Transfer to reastaurant |
13:00-14:00 | Lunch at “Russian Versailles” restaurant |
14:00-16:00 | Excursion to Peterhof Park |
17:00-18:00 | Transfer to hotel |
18:00-20:00 | Dinner (Astoria Hotel) |
7:00-9:00 | Breakfast (Angleterre Hotel, Michele restaurant) |
9:00-10:00 | Free time (Gathering of guests in the hotel lobby at 9:45) |
10:00-13:00 | Excursin to the Hermitage Museum / Shopping at Galeria Mall |
13:00-15:00 | Lunch (Astoria Hotel) |
15:00-18:00 | Free time |
19:00-22:00 | Dinner (Astoria Hotel) |
- Breakfast, lunch & dinner provided at the hotel
- Transfer to the airport
- Departure from St. Petersburg
Program
July 2, 2025 13:00-17:00
Astoria Hotel, “Ballroom”
Dialogue for the Future: Shaping Tomorrow’s Care in Oncology
I. BIOCAD company’s Journey: A Self-Narrated History
Moderator
Irina Khlopotkina, Therapeutic area head (onco-2), Russia
Experts
Irina Sorokina, PhD, Global Medical Affairs Lead, Russia
Sergei Fogt, MD, PhD, Head of Early Clinical Development Unit, Russia
Sergei Fogt, MD, PhD, Head of Early Clinical Development Unit, Russia
Presentation Program
13:00-13:20
A BIOCAD’s History: The Inside Perspective
Irina Sorokina
Irina Sorokina
13:20-13:40
Clinical development & registration of molecules — A challenge driven approach
Sergei Fogt
Sergei Fogt
II. Biosimilars: Ensuring Confidence in Tomorrow’s Healthcare
Moderator
Alexey Tryakin, MD, PhD, Professor, Deputy Director at the N.N. Blokhin National Medical Research Center of Oncology, Head of Oncology Department, Chairman of the groups for the development of clinical guidelines of the Russian Ministry of Health, dedicated to the treatment of cancer of the esophagus, colon and rectum, germ cell tumors. Member of the boards of the Russian Society of Clinical Oncology, Russia
Experts
Alexey Tryakin, MD, PhD, Professor, Deputy Director at the N.N. Blokhin National Medical Research Center of Oncology, Head of Oncology Department, Chairman of the groups for the development of clinical guidelines of the Russian Ministry of Health, dedicated to the treatment of cancer of the esophagus, colon and rectum, germ cell tumors. Member of the boards of the Russian Society of Clinical Oncology, Russia
Lyudmila Zhukova, MD, PhD, Corresponding Member of the Russian Academy of Sciences, Deputy Director at the A. S. Loginov Moscow Clinical Scientific Center, Head of the Chemotherapy Department, Chairman of the groups for the development of clinical guidelines of the Russian Ministry of Health, dedicated to the treatment of breast cancer. Member of the boards of the Russian Society of Clinical Oncology, Russia
Ilya Tsimafeyeu, M.D. Director, Bureau for Cancer Research - BUCARE (Russia); Medical Oncologist, STOONCO clinic (Russia); Board Member, ASCO Central and Eastern European Committee (USA); Faculty Member and Mentor, The College of the European School of Oncology (Italy)
Lyudmila Zhukova, MD, PhD, Corresponding Member of the Russian Academy of Sciences, Deputy Director at the A. S. Loginov Moscow Clinical Scientific Center, Head of the Chemotherapy Department, Chairman of the groups for the development of clinical guidelines of the Russian Ministry of Health, dedicated to the treatment of breast cancer. Member of the boards of the Russian Society of Clinical Oncology, Russia
Ilya Tsimafeyeu, M.D. Director, Bureau for Cancer Research - BUCARE (Russia); Medical Oncologist, STOONCO clinic (Russia); Board Member, ASCO Central and Eastern European Committee (USA); Faculty Member and Mentor, The College of the European School of Oncology (Italy)
Presentation Program
13:40-14:00
14:00-14:20
Confidence and Necessity: Advancing HER2+ Breast Cancer Care with Trastuzumab and Pertuzumab Biosimilars
Lyudmila Zhukova
Lyudmila Zhukova
14:20-14:40
14:40-15:00
Coffee break
III. Designing Future Therapies: The Path of Original Drug Development
Moderator
Daniil Stroyakovsky, MD, PhD, Head of the Chemotherapy Department, Moscow City Oncology Hospital No. 62, Moscow Healthcare Department, Member of the working group for the development of clinical guidelines of the Russian Ministry of Health on melanoma and lung cancer, Russia
Experts
Kristina Orlova, MD, PhD, Senior Research Fellow at the Department of Drug Therapy (Skin Tumors Division), Pediatric Oncologist at the N.N. Blokhin National Medical Research Center of Oncology, Member of the working group for the development of clinical guidelines of the Russian Ministry of Health on melanoma. Member of the boards of the professional association MelanomaPro, Russia
Daniil Stroyakovsky, MD, PhD, Head of the Chemotherapy Department, Moscow City Oncology Hospital No. 62, Moscow Healthcare Department, Member of the working group for the development of clinical guidelines of the Russian Ministry of Health on melanoma and lung cancer, Russia
Alexey Tryakin, MD, PhD, Professor, Deputy Director at the N.N. Blokhin National Medical Research Center of Oncology, Head of Oncology Department, Chairman of the groups for the development of clinical guidelines of the Russian Ministry of Health, dedicated to the treatment of cancer of the esophagus, colon and rectum, germ cell tumors. Member of the boards of the Russian Society of Clinical Oncology, Russia
Elias Gracia, MD, Professor, Head of Medical Oncology Department at National Institute of Oncology and Radiobiology, Habana, Cuba
Daniil Stroyakovsky, MD, PhD, Head of the Chemotherapy Department, Moscow City Oncology Hospital No. 62, Moscow Healthcare Department, Member of the working group for the development of clinical guidelines of the Russian Ministry of Health on melanoma and lung cancer, Russia
Alexey Tryakin, MD, PhD, Professor, Deputy Director at the N.N. Blokhin National Medical Research Center of Oncology, Head of Oncology Department, Chairman of the groups for the development of clinical guidelines of the Russian Ministry of Health, dedicated to the treatment of cancer of the esophagus, colon and rectum, germ cell tumors. Member of the boards of the Russian Society of Clinical Oncology, Russia
Elias Gracia, MD, Professor, Head of Medical Oncology Department at National Institute of Oncology and Radiobiology, Habana, Cuba
Presentation Program
15:00-15:20
15:20-15:40
Prolgolimab for patients with NSCLC: Domajor as a Symphony of Victory
Daniil Stroyakovsky
Download the Presentation
Daniil Stroyakovsky
Download the Presentation
15:40-16:00
Prolgolimab in Neoadjuvant Therapy for Patients with CRC: Exceeding Expectations
Alexey Tryakin
Download the Presentation
Alexey Tryakin
Download the Presentation
16:00-16:40
Immunotherapy with Prolgolimab and Pembrolizumab Biosimilar: Cuban expanded use program
Elias Gracia
Download the Presentation
Elias Gracia
Download the Presentation
16:40-17:00
Concluding Remarks and feedback
All participants
All participants
July 3, 2025 13:15-14:15
Cosmos Pribaltiyskaya Hotel, Blue 5
Satellite symposium as part of the International Oncology Forum "White Nights 2025"
Biocad Production studio presents. The star duo of domestic immuno-oncology
Chairmen
Alexey Novik, MD, Oncologist, Leading Researcher, N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of the Russian Federation
Carlos Gil Ferreira, President of Oncoclinicas Institute, Medical Director of Oncoclinicas, President of Oncoclinicas Institute, CMO - Oncoclinicas, IASLC Board Member, Brazil
Carlos Gil Ferreira, President of Oncoclinicas Institute, Medical Director of Oncoclinicas, President of Oncoclinicas Institute, CMO - Oncoclinicas, IASLC Board Member, Brazil
Experts
Kristina Orlova, MD, PhD, Senior Research Fellow at the Department of Drug Therapy (Skin Tumors Division), Pediatric Oncologist at the N.N. Blokhin National Medical Research Center of Oncology, Member of the working group for the development of clinical guidelines of the Russian Ministry of Health on melanoma. Member of the boards of the professional association MelanomaPro, Russia
Alexey Novik, D.Sc. in Medicine, Oncologist of the Department of Antitumor Drug Therapy, Oncologist of the Department of Organizational and Methodological Work with Regions, Senior Research Fellow of the Research Division for Cancer Immunology of the NMRC of Oncology named after N.N. Petrov of MoH of Russia, St. Petersburg
Fedor V. Moiseenko MD, Head of the Chemotherapy Department No. 1 of the SBHI "St. Petersburg KNPC UHMC (Oncology) named after N.P. Napalkov," doctor of the highest qualification category, associate professor of oncology SBEI HPE "North-Western State Medical University named after I.I. Mechnikov" of the Ministry of Health
Svetlana Odintsova, D.Sc. in Medicine, Oncologist of the Department of Antitumor Drug Therapy, Oncologist of the Department of Organizational and Methodological Work with Regions, Senior Research Fellow of the Research Division for Cancer Immunology of the NMRC of Oncology named after N.N. Petrov of MoH of Russia, St. Petersburg
Alexey Novik, D.Sc. in Medicine, Oncologist of the Department of Antitumor Drug Therapy, Oncologist of the Department of Organizational and Methodological Work with Regions, Senior Research Fellow of the Research Division for Cancer Immunology of the NMRC of Oncology named after N.N. Petrov of MoH of Russia, St. Petersburg
Fedor V. Moiseenko MD, Head of the Chemotherapy Department No. 1 of the SBHI "St. Petersburg KNPC UHMC (Oncology) named after N.P. Napalkov," doctor of the highest qualification category, associate professor of oncology SBEI HPE "North-Western State Medical University named after I.I. Mechnikov" of the Ministry of Health
Svetlana Odintsova, D.Sc. in Medicine, Oncologist of the Department of Antitumor Drug Therapy, Oncologist of the Department of Organizational and Methodological Work with Regions, Senior Research Fellow of the Research Division for Cancer Immunology of the NMRC of Oncology named after N.N. Petrov of MoH of Russia, St. Petersburg
Presentation Program
13:15-13:20
Introduction
Alexey V. Novik
Alexey V. Novik
13:20-13:35
From pilot rolls to the birth of blockbusters in Russian immunotherapy
Alexey V. Novik
Alexey V. Novik
13:35-13:50
FORA — to be continued. Longer observation, stronger confidence in success!
Christina V. Orlova
Christina V. Orlova
13:50-14:05
Thriller with a Happy Ending: the main conclusions from the DOMAJOR Study
Fedor V. Moiseenko
Fedor V. Moiseenko
14:05-14:15
Forteca in NSCLC. Movie etude from real practice
Svetlana V. Odintsova
Svetlana V. Odintsova
July 3, 2025 15:50-16:25
Cosmos Pribaltiyskaya Hotel
Plenary reports as part of the congress’s scientific program
Experts
Lyudmila Zhukova, MD, PhD, Corresponding Member of the Russian Academy of Sciences, Deputy Director at the A. S. Loginov Moscow Clinical Scientific Center, Head of the Chemotherapy Department, Chairman of the groups for the development of clinical guidelines of the Russian Ministry of Health, dedicated to the treatment of breast cancer. Member of the boards of the Russian Society of Clinical Oncology, Russia
Sergei Fogt, MD, PhD, Head of Early Clinical Development Unit, Russia
Sergei Fogt, MD, PhD, Head of Early Clinical Development Unit, Russia
Presentation Program
15:50-16:05
Efficacy and safety of biosimilar pertuzumab in neoadjuvant therapy of HER2+ breast cancer. Results of the PREFER phase III clinical trial
Liudmila G. Zhukova
Liudmila G. Zhukova
16:10-16:25
Evolution of neoadjuvant therapy for biologically aggressive subtypes of breast cancer: the role of biosimilars
Sergei N. Fogt
Sergei N. Fogt
About BIOCAD
BIOCAD is a fully integrated biotechnology company with in-house capabilities from new molecules discovery to large-scale commercial manufacturing and marketing.
Today BIOCAD is focused on developing original drugs, best-in-class and first-in-class, for immuno-oncology, hematology and autoimmune diseases treatment.
Today BIOCAD is focused on developing original drugs, best-in-class and first-in-class, for immuno-oncology, hematology and autoimmune diseases treatment.
30
countries of export
total production area
83 250
m2
5
international offices
product registrations
>200
laboratories
>40
treated patients
>250 000
5
industrial facilities
Products
BIOCAD’s portfolio includes more than 60 products; more than 20 of them are biological. Here you may find the list of our bestselling products, which we are already exporting or are ready to export in the near future.
Publications
Local Contact Details
Name/Surname
Svetlana Bas
Sofia Eseva
Sofia Eseva
Position
Senior Project Manager
Global Strategic Marketing Manager
Global Strategic Marketing Manager
Mob., WhatsApp
+7 981 131 65 40
+7 961 761 68 64
+7 961 761 68 64
JSC “BIOCAD”
Adress
198515, Saint Petersburg, Intracity Municipality the Settlement of Strelna, ul. Svyazi, d. 38, str. 1, pomeshch. 89
Contact
Dear visitors
This website is a specialized resource for medical and pharmaceutical professionals. If you are not one of these specialists, please leave this site. By continuing to use the resource, I confirm that I am a professional with a medical or pharmaceutical background and that the information obtained from the site may only be used by me for professional purposes.
This website uses cookies to better understand how visitors use our site, for advertising, and to offer you a more personalized experience. We share information about your use of our site with analytics according with Cookie Notice